JP2022512373A5 - - Google Patents
Info
- Publication number
- JP2022512373A5 JP2022512373A5 JP2021533340A JP2021533340A JP2022512373A5 JP 2022512373 A5 JP2022512373 A5 JP 2022512373A5 JP 2021533340 A JP2021533340 A JP 2021533340A JP 2021533340 A JP2021533340 A JP 2021533340A JP 2022512373 A5 JP2022512373 A5 JP 2022512373A5
- Authority
- JP
- Japan
- Prior art keywords
- disorder
- disorders
- disease
- compound
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18212060.0 | 2018-12-12 | ||
| EP18212060 | 2018-12-12 | ||
| PCT/EP2019/084375 WO2020120450A1 (en) | 2018-12-12 | 2019-12-10 | Substituted xanthine derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022512373A JP2022512373A (ja) | 2022-02-03 |
| JP2022512373A5 true JP2022512373A5 (https=) | 2022-12-16 |
| JP7502299B2 JP7502299B2 (ja) | 2024-06-18 |
Family
ID=64665184
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021533340A Active JP7502299B2 (ja) | 2018-12-12 | 2019-12-10 | 置換キサンチン誘導体 |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US11198696B2 (https=) |
| EP (1) | EP3894410B1 (https=) |
| JP (1) | JP7502299B2 (https=) |
| KR (1) | KR102877857B1 (https=) |
| CN (1) | CN113166151B (https=) |
| AU (1) | AU2019396499B2 (https=) |
| BR (1) | BR112021008316A2 (https=) |
| CL (1) | CL2021001509A1 (https=) |
| DK (1) | DK3894410T3 (https=) |
| EA (1) | EA202191588A1 (https=) |
| ES (1) | ES2964630T3 (https=) |
| HU (1) | HUE064908T2 (https=) |
| IL (1) | IL283768B2 (https=) |
| MX (1) | MX2021007019A (https=) |
| PH (1) | PH12021551345A1 (https=) |
| PL (1) | PL3894410T3 (https=) |
| TW (1) | TWI825243B (https=) |
| WO (1) | WO2020120450A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12064917B2 (en) | 2012-11-21 | 2024-08-20 | Stratasys, Inc. | Method for printing three-dimensional parts with cyrstallization kinetics control |
| HUE064908T2 (hu) * | 2018-12-12 | 2024-04-28 | Boehringer Ingelheim Int | Szubsztituált xantinszármazékok |
| WO2024164818A1 (zh) * | 2023-02-08 | 2024-08-15 | 中国科学院上海药物研究所 | 黄嘌呤类化合物及其用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107082782B (zh) | 2013-03-15 | 2020-03-20 | 海德拉生物科学有限责任公司 | 取代的黄嘌呤及其使用方法 |
| WO2016023830A1 (en) | 2014-08-11 | 2016-02-18 | Hydra Biosciences, Inc. | Pyrido[2,3-d]pyrimidine-2,4(1h,3h)-dione derivatives |
| GB201702160D0 (en) | 2017-02-09 | 2017-03-29 | Univ Leeds Innovations Ltd | Inhibitors for use in therapy |
| DK3652176T3 (da) * | 2017-07-11 | 2022-01-17 | Boehringer Ingelheim Int | Substituerede xanthinderivater |
| HUE064908T2 (hu) * | 2018-12-12 | 2024-04-28 | Boehringer Ingelheim Int | Szubsztituált xantinszármazékok |
-
2019
- 2019-12-10 HU HUE19820718A patent/HUE064908T2/hu unknown
- 2019-12-10 DK DK19820718.5T patent/DK3894410T3/da active
- 2019-12-10 WO PCT/EP2019/084375 patent/WO2020120450A1/en not_active Ceased
- 2019-12-10 CN CN201980081737.1A patent/CN113166151B/zh active Active
- 2019-12-10 PL PL19820718.5T patent/PL3894410T3/pl unknown
- 2019-12-10 AU AU2019396499A patent/AU2019396499B2/en active Active
- 2019-12-10 KR KR1020217021875A patent/KR102877857B1/ko active Active
- 2019-12-10 EA EA202191588A patent/EA202191588A1/ru unknown
- 2019-12-10 EP EP19820718.5A patent/EP3894410B1/en active Active
- 2019-12-10 MX MX2021007019A patent/MX2021007019A/es unknown
- 2019-12-10 JP JP2021533340A patent/JP7502299B2/ja active Active
- 2019-12-10 ES ES19820718T patent/ES2964630T3/es active Active
- 2019-12-10 PH PH1/2021/551345A patent/PH12021551345A1/en unknown
- 2019-12-10 IL IL283768A patent/IL283768B2/en unknown
- 2019-12-10 BR BR112021008316-2A patent/BR112021008316A2/pt unknown
- 2019-12-11 US US16/710,887 patent/US11198696B2/en active Active
- 2019-12-12 TW TW108145593A patent/TWI825243B/zh active
-
2021
- 2021-06-09 CL CL2021001509A patent/CL2021001509A1/es unknown
- 2021-11-10 US US17/523,316 patent/US20220177479A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022512373A5 (https=) | ||
| JP2012521994A5 (https=) | ||
| RU2015143466A (ru) | Нейроактивные стероиды и способы их применения | |
| JP2015512951A5 (https=) | ||
| HRP20220029T1 (hr) | Supstituirani derivati ksantina | |
| JP2018070614A5 (https=) | ||
| JP2010520265A5 (https=) | ||
| JP2016513663A5 (https=) | ||
| EA201692558A1 (ru) | Производные индолин-2-она или пирролопиридин-2-она | |
| JP2015509534A5 (https=) | ||
| CA2599890A1 (en) | Substituted pyridine derivatives | |
| JP2019525939A5 (https=) | ||
| JP2022512374A5 (https=) | ||
| JP2018508592A5 (https=) | ||
| EA201990450A1 (ru) | Ингибиторы киназы, содержащей домен с двумя лейциновыми "застежками-молниями" (dlk), для лечения заболевания | |
| BRPI0410378A (pt) | tratamento de distúrbios psicóticos e depressivos | |
| JP2019516739A5 (https=) | ||
| JP2015508092A5 (https=) | ||
| JP2020526591A5 (https=) | ||
| JP2020504156A5 (https=) | ||
| RU2017112989A (ru) | Соединения и способы | |
| JP2016537432A5 (https=) | ||
| JP2025527291A5 (https=) | ||
| CA3032141A1 (en) | Compounds and compositions and uses thereof | |
| JP2022510587A5 (https=) |